Condition: Breast Cancer · Sponsor: Greenwich LifeSciences, Inc.
This is a prospective, randomized, double-blinded, placebo-controlled, multi-center, Phase 3 study of GLSI-100 immunotherapy in HLA-A\*02 positive and HER2/neu positive subjects who are at high risk for disease recurrence and have completed both neoadjuvant and postoperative adjuvant standard of care therapy. Treatment consists of 6 intradermal injections, Primary Immunization Series (PIS), over the first 6 months of treatment and 5 booster intradermal injections spaced 6 months apart. A third open-label arm will explore GLSI-100 immunotherapy in non-HLA-A\*02 positive and HER2/neu positive subjects.
This description comes directly from the study's public registry record.
Jaye L Thompson, Ph.D. · (832) 791-2542 · Jaye.Thompson@GreenwichLifeSciences.com
Always discuss trial participation with your own doctor first.
| Southern Cancer Center | Mobile, Alabama, United States | Not Yet Recruiting |
| City of Hope - Cancer Center Phoenix | Goodyear, Arizona, United States | Recruiting |
| Tucson Medical Center HealthCare | Tucson, Arizona, United States | Recruiting |
| City of Hope - Duarte Cancer Center | Duarte, California, United States | Recruiting |
| Providence St. Jude Medical Center - Virginia K. Crosson Cancer Center | Fullerton, California, United States | Recruiting |
| City of Hope - Orange County Lennar Foundation Cancer Center | Irvine, California, United States | Recruiting |
| University of California San Diego - Moores Cancer Center | La Jolla, California, United States | Recruiting |
| University of Southern California - Norris Comprehensive Cancer Center | Los Angeles, California, United States | Active Not Recruiting |
| Stanford Medicine Cancer Center - Stanford Women's Cancer Center | Palo Alto, California, United States | Recruiting |
| University of California San Francisco - Helen Diller Family Comprehensive Cancer Center | San Francisco, California, United States | Recruiting |
| University of California Los Angeles - Hematology / Oncology Parkside | Santa Monica, California, United States | Recruiting |
| PIH Health Hospital - Whittier Hospital | Whittier, California, United States | Recruiting |
+ 167 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05232916